HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Cao Selected Research

IS 35

1/2022Neuroplasticity of Glioma Patients: Brain Structure and Topological Network.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Cao Research Topics

Disease

36Neoplasms (Cancer)
05/2022 - 05/2008
18Hearing Loss (Hearing Impairment)
10/2021 - 12/2004
11Deafness (Deaf Mutism)
01/2020 - 08/2006
9Infections
01/2022 - 10/2011
9Breast Neoplasms (Breast Cancer)
01/2020 - 05/2008
9Atrioventricular Block
01/2020 - 11/2014
8Carcinogenesis
01/2019 - 05/2008
7Hypertension (High Blood Pressure)
02/2022 - 06/2015
7Inflammation (Inflammations)
01/2022 - 01/2016
7Heart Failure
08/2021 - 01/2013
6Liver Neoplasms (Liver Cancer)
09/2021 - 06/2008
6Obstructive Sleep Apnea
06/2020 - 04/2013
6Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 07/2009
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2013 - 09/2009
5Virus Diseases (Viral Diseases)
11/2021 - 02/2016
5Neoplasm Metastasis (Metastasis)
09/2021 - 01/2017
5Nonsyndromic Deafness
01/2019 - 08/2006
5Long QT Syndrome
01/2018 - 02/2015
5Torsades de Pointes (Torsade de Pointes)
08/2017 - 06/2015
4Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 06/2016
4Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
4Atrial Fibrillation
08/2021 - 02/2016
4Atherosclerosis
02/2021 - 07/2019
4Lymphoma (Lymphomas)
01/2021 - 06/2012
4Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 08/2006
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2015 - 06/2012
3Fibrosis (Cirrhosis)
04/2022 - 01/2021
3Genomic Instability
02/2022 - 01/2020
3Adenocarcinoma of Lung
05/2021 - 01/2017
3Cardiac Arrhythmias (Arrythmia)
02/2021 - 01/2016
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 01/2016
3Shock
12/2020 - 04/2018
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2020 - 05/2016
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2020
2Diabetic Retinopathy (Retinopathy, Diabetic)
05/2022 - 05/2021
2Ganglion Cysts (Ganglion)
03/2022 - 07/2018
2Bites and Stings (Sting)
01/2022 - 12/2021
2Human Influenza (Influenza)
01/2022 - 05/2016
2Obesity
01/2022 - 05/2021
2Chickenpox
11/2021 - 11/2021
2Hepatocellular Carcinoma (Hepatoma)
09/2021 - 09/2015
2Atrial Remodeling
08/2021 - 02/2018
2Hyperlipidemias (Hyperlipidemia)
02/2021 - 01/2017
2Hyperglycemia
01/2021 - 03/2019
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2021 - 01/2016
2Diarrhea
01/2021 - 06/2018
2Lung Neoplasms (Lung Cancer)
01/2021 - 10/2020
2Body Weight (Weight, Body)
01/2021 - 08/2020
2Ventricular Tachycardia
12/2019 - 06/2016
2Hemorrhage
07/2019 - 07/2019

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2008
12Pharmaceutical PreparationsIBA
01/2021 - 02/2014
912S ribosomal RNAIBA
07/2013 - 12/2004
7Messenger RNA (mRNA)IBA
01/2022 - 05/2008
7VaccinesIBA
11/2021 - 07/2020
6DNA (Deoxyribonucleic Acid)IBA
02/2022 - 10/2008
6Mitochondrial DNA (mtDNA)IBA
09/2015 - 12/2004
5CytokinesIBA
05/2022 - 01/2013
5Biological ProductsIBA
01/2020 - 03/2015
5Halothane (Fluothane)FDA Link
12/2017 - 06/2015
5AminoglycosidesIBA
02/2013 - 06/2006
4ORALIT (ORS)IBA
05/2022 - 12/2015
4Tyrosine Kinase InhibitorsIBA
05/2021 - 01/2018
4SurvivinIBA
01/2021 - 08/2009
4MicroRNAs (MicroRNA)IBA
01/2021 - 03/2013
4Amyloid (Amyloid Fibrils)IBA
01/2020 - 09/2013
4oxysterol binding proteinIBA
01/2020 - 05/2016
4Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 09/2009
4FlavonoidsIBA
06/2017 - 01/2015
4EnzymesIBA
07/2016 - 06/2008
3Interferon Type IIBA
01/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
3Insulin (Novolin)FDA Link
01/2021 - 01/2016
3LFG-500IBA
06/2017 - 01/2016
3Ser Transfer RNAIBA
09/2011 - 08/2006
3Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
12/2009 - 07/2009
2Adenosine Triphosphate (ATP)IBA
02/2022 - 01/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 06/2017
2Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
02/2022 - 01/2022
2Synthetic Vaccines (Recombinant Vaccines)IBA
01/2022 - 08/2021
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 10/2019
2Malondialdehyde (Propanedial)IBA
01/2022 - 11/2021
2UbiquitinIBA
12/2021 - 10/2017
2RetinoidsIBA
09/2021 - 11/2018
2Guan-fu base AIBA
08/2021 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
05/2021 - 01/2020
2CateninsIBA
05/2021 - 01/2020
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 10/2015
2InterleukinsIBA
01/2021 - 08/2009
2Biopolymers (Biopolymer)IBA
12/2020 - 01/2019
2Heavy MetalsIBA
12/2020 - 01/2019
2InterferonsIBA
09/2020 - 01/2018
2Antiviral Agents (Antivirals)IBA
09/2020 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2013
2AnticoagulantsIBA
07/2019 - 07/2019

Therapy/Procedure

25Therapeutics
05/2022 - 06/2008
6Drug Therapy (Chemotherapy)
01/2021 - 05/2015
4Aftercare (After-Treatment)
05/2021 - 08/2010
3Continuous Positive Airway Pressure
06/2020 - 10/2014
2Oral Administration
02/2021 - 01/2019